Lebrikizumab

Item number	Size	Datasheet	Manual	SDS	Delivery time	Price
BPS-82692-1	1 mg	-	-	-	3 - 15 business days*	742.00€
BPS-82692-2	5 mg	-	-	-	3 - 15 business days*	1,646.00€
BPS-82692-3	10 mg	-	-	-	3 - 15 business days*	2,508.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Lebrikizumab (TNX-650) is an IgG4 humanized anti-interleukin-13 (IL-13) mAb with anti-itch... more

Close menu

Product information "Lebrikizumab"

Lebrikizumab (TNX-650) is an IgG4 humanized anti-interleukin-13 (IL-13) mAb with anti-itch effects that specifically binds to IL-13 in a non-receptor binding domain and inhibits its function. Lebrikizumab inhibits the IL-13 driven Th2 inflammatory response and blocks the signaling of IL-4Ralpha/IL-13Ralpha1. Lebrikizumab can be used for the research of asthma, atopic dermatitis and neuroinflammatory diseases1,2,3.

Keywords:	Anti-IL13, Anti-NC30, Anti-IL-13, Anti-Interleukin-13,
Supplier:	BPS Bioscience
Supplier-Nr:	82692

Properties

Application:	Immune cell signaling studies
Conjugate:	No
Species reactivity:	human
MW:	49/23 kD
Format:	Solution

Database Information

KEGG ID :	K05435 \| Matching products
UniProt ID :	P35225 \| Matching products
Gene ID :	GeneID 3596 \| Matching products

Handling & Safety

Storage:	-80°C
Shipping:	-80°C (International: -80°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

View product citations for antibody 82692 on CiteAb

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "Lebrikizumab"

Write a review